These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27019190)

  • 1. A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.
    Wang X; Wei Y; Xiao H; Liu X; Zhang Y; Han G; Chen G; Hou C; Ma N; Shen B; Li Y; Egwuagu CE; Wang R
    Eur J Immunol; 2016 Jun; 46(6):1343-50. PubMed ID: 27019190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice.
    Wang X; Liu X; Zhang Y; Wang Z; Zhu G; Han G; Chen G; Hou C; Wang T; Ma N; Shen B; Li Y; Xiao H; Wang R
    Clin Exp Immunol; 2016 Nov; 186(2):144-156. PubMed ID: 27400195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for expression and function of IL-39 in human immune cells.
    Ecoeur F; Weiss J; Schleeger S; Guntermann C
    PLoS One; 2020; 15(12):e0242329. PubMed ID: 33259477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes.
    Ramnath D; Tunny K; Hohenhaus DM; Pitts CM; Bergot AS; Hogarth PM; Hamilton JA; Kapetanovic R; Sturm RA; Scholz GM; Sweet MJ
    Immunol Cell Biol; 2015 Oct; 93(9):771-9. PubMed ID: 26303210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.
    Smith S; Gabhann JN; Higgs R; Stacey K; Wahren-Herlenius M; Espinosa A; Totaro MG; Sica A; Ball E; Bell A; Johnston J; Browne P; O'Neill L; Kearns G; Jefferies CA
    Arthritis Rheum; 2012 May; 64(5):1601-9. PubMed ID: 22127978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-23 deficiency alters thymic selection in lupus-prone mice.
    Dai H; Kyttaris VC
    Lupus; 2019 Jul; 28(8):1007-1012. PubMed ID: 31166866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebi3 promotes T- and B-cell division and differentiation via STAT3.
    Ma N; Fang Y; Xu R; Zhai B; Hou C; Wang X; Jiang Z; Wang L; Liu Q; Han G; Wang R
    Mol Immunol; 2019 Mar; 107():61-70. PubMed ID: 30660991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man.
    Bridgewood C; Alase A; Watad A; Wittmann M; Cuthbert R; McGonagle D
    Inflamm Res; 2019 Jun; 68(6):423-426. PubMed ID: 30989239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK-ERK signaling diametrically controls the stimulation of IL-23p19 and EBI3 expression in epithelial cells by IL-36γ.
    Scholz GM; Heath JE; Walsh KA; Reynolds EC
    Immunol Cell Biol; 2018 Jul; 96(6):646-655. PubMed ID: 29474749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 39: a new member of interleukin 12 family.
    Lu Z; Xu K; Wang X; Li Y; Li M
    Cent Eur J Immunol; 2020; 45(2):214-217. PubMed ID: 33456334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-35 subunit EBI3 alleviates bleomycin-induced pulmonary fibrosis via suppressing DNA enrichment of STAT3.
    Chen D; Zheng G; Yang Q; Luo L; Shen J
    Respir Res; 2021 Oct; 22(1):280. PubMed ID: 34711217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic histone modulation contributes to improvements in inflammatory bowel disease via EBI3.
    Wetzel A; Scholtka B; Gerecke C; Kleuser B
    Cell Mol Life Sci; 2020 Dec; 77(23):5017-5030. PubMed ID: 31955243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis.
    Igawa T; Nakashima H; Sadanaga A; Masutani K; Miyake K; Shimizu S; Takeda A; Hamano S; Yoshida H
    Mod Rheumatol; 2009; 19(1):33-41. PubMed ID: 18779924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.
    Ma Y; Chen L; Xie G; Zhou Y; Yue C; Yuan X; Zheng Y; Wang W; Deng L; Shen L
    Oncotarget; 2016 Nov; 7(45):73003-73015. PubMed ID: 27682874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.
    Liang Y; Chen Q; Du W; Chen C; Li F; Yang J; Peng J; Kang D; Lin B; Chai X; Zhou K; Zeng J
    Mediators Inflamm; 2016; 2016():3214105. PubMed ID: 27247488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.